First E-Cigarette Flavor and Device Type Used: Associations With Vaping Persistence, Frequency, and Dependence in Young Adults.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
14 02 2022
14 02 2022
Historique:
received:
28
03
2021
accepted:
27
08
2021
pubmed:
31
8
2021
medline:
1
4
2022
entrez:
30
8
2021
Statut:
ppublish
Résumé
Type of e-cigarette flavoring and device during first use might differentiate later e-cigarette use and dependence. This retrospective cross-sectional study examined associations of recalled first nicotine vaping device and flavor used with current vaping frequency/dependence. A young adult cohort from Los Angeles, California, USA completed web-based surveys (N = 2553). Using cross-sectional data from 971 reporting ever vaping nicotine, multivariable hurdle regressions tested associations between recalled first flavor (fruit/sweet, menthol/mint, other) and device (Juul, disposable, mod, box, pod, pen, other) vaped with past-30-day vaping status (yes/no) and frequency (1-30 days), and with any vaping dependence symptoms (yes/no) and count (1-10 symptoms). The most common first-flavor was sweet (71%); the most common first-device was a vape pen (37%), then Juul (22%). First-flavor of mint/menthol (vs. other; adjusted odds ratio [AOR]: 2.22[95% CI = 1.16 to 4.25]), and first-device mod (AOR = 2.40[95% CI = 1.34 to 4.31]) and non-Juul pod (2.64[95% CI = 1.41 to 4.92]) (vs. pen) were associated with past-30-day vaping, and twice as many vaping days (adjusted rate ratios [ARRs] range: 1.96-2.12; ps < .05). First flavor of mint/menthol (vs. other; AOR: 1.95[95% CI = 1.003 to 3.79) and first device mod, box, non-Juul pod, and other (AORs range: 2.36-4.01; ps < .05) were associated with nicotine dependence. First device Juul, mod, box, and non-Juul pod were also associated with more dependence symptoms (ARRs range:1.38-1.59; ps < .05). Exposure to mint/menthol and certain devices (mod, box, Juul, and non-Juul pods) at first e-cigarette use may be associated with more frequent e-cigarette use and nicotine dependence symptoms in young adulthood. Mint/menthol and certain devices warrant consideration in regulation of e-cigarettes based on product characteristics. Characteristics (flavor and device type) of first e-cigarette product used were associated with higher usage and more dependence. Pending replication with prospective designs, the findings suggest certain flavors (mint/menthol) and devices (pods, mods) merit consideration in regulation because of their possible link with continued use and dependence among young people.
Identifiants
pubmed: 34460934
pii: 6359789
doi: 10.1093/ntr/ntab172
pmc: PMC8842392
doi:
Substances chimiques
Flavoring Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
380-387Subventions
Organisme : NIDA NIH HHS
ID : K01 DA042950
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA229617
Pays : United States
Organisme : NIDA NIH HHS
ID : K24 DA048160
Pays : United States
Organisme : FDA HHS
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA180905
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
JAMA Netw Open. 2021 Jan 4;4(1):e2032757
pubmed: 33433597
J Adolesc Health. 2018 Nov;63(5):582-586
pubmed: 30348280
Exp Clin Psychopharmacol. 2020 Oct;28(5):527-539
pubmed: 31855003
Curr Addict Rep. 2019 Jun;6(2):98-113
pubmed: 31453046
Arch Pediatr Adolesc Med. 2002 Apr;156(4):397-403
pubmed: 11929376
Drug Alcohol Depend. 2017 Sep 1;178:391-398
pubmed: 28704768
N Engl J Med. 2010 Jun 17;362(24):2295-303
pubmed: 20554984
JAMA Pediatr. 2017 Dec 1;171(12):1192-1199
pubmed: 29059261
Addict Behav. 2020 Aug;107:106403
pubmed: 32222565
Drug Alcohol Depend. 2018 Jul 1;188:109-112
pubmed: 29763848
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681
N Engl J Med. 2019 Jan 10;380(2):192-193
pubmed: 30554549
Curr Neuropharmacol. 2018;16(4):438-459
pubmed: 29046158
JAMA. 2015 Aug 18;314(7):700-7
pubmed: 26284721
Addict Behav. 2017 Oct;73:151-157
pubmed: 28521240
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1313-1318
pubmed: 32941416
Drug Alcohol Depend. 2019 Sep 1;202:149-155
pubmed: 31351341
PLoS One. 2018 Jan 4;13(1):e0189015
pubmed: 29300749
Int J Environ Res Public Health. 2019 Aug 20;16(16):
pubmed: 31434229
Drug Alcohol Depend. 2018 Oct 1;191:279-285
pubmed: 30165328
JAMA Netw Open. 2020 Feb 5;3(2):e1921513
pubmed: 32074292
J Youth Adolesc. 1991 Apr;20(2):149-66
pubmed: 24265004
Drug Alcohol Depend. 2019 Jan 1;194:395-400
pubmed: 30497057
Tob Control. 2020 Nov;29(6):679-686
pubmed: 31852818
Nicotine Tob Res. 2015 Oct;17(10):1242-6
pubmed: 25744966
Pediatrics. 2019 Nov;144(5):
pubmed: 31659004
Neuropsychopharmacology. 2017 Nov;42(12):2285-2291
pubmed: 28401925
Addict Behav. 2014 Sep;39(9):1372-6
pubmed: 24636739
Drug Alcohol Depend. 2017 Nov 1;180:193-199
pubmed: 28915478
Nicotine Tob Res. 2015 Feb;17(2):158-62
pubmed: 25180079
JAMA. 2019 Nov 12;322(18):1824-1827
pubmed: 31524940
N Engl J Med. 2018 Sep 20;379(12):1099-1102
pubmed: 30134127